Guilhem Richard

Chief Scientific Officer / Chief Technology Officer at EpiVax Therapeutics

Guilhem Richard brings immunoinformatics expertise to the EpiVax Therapeutics team. He has been a Computational Immunologist for over 4 years at EpiVax, focusing on refining its immuno-oncology platform. He holds a Master of Engineering in Bioinformatics and Modeling from the National Institute of Applied Sciences (INSA) of Lyon, France, and a Ph.D. in Bioinformatics from Boston University.

Links

Previous companies

Boston University logo
EpiVax, Inc. logo